Document

All Funds Gross and Net Returns

Dated March 31, 2014 Ref IMAGES-007-HOUSE_OVERSIGHT_024105.txt Release House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pages

Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.

View the original on the official release

Document text

Text is machine OCR and may contain errors. Confirm against the original source above.

Appendix 2 All Funds Gross and Net Returns $ amounts in millions, as of March 31, 2014 Total Cost Realized Unrealized Realized Overall Realized Overall New Leaf Ventures II, L.P. (2008) New Leaf Ventures I, L.P. (2005) Sprout Capital IX, L.P. (2000) (Healthcare Technology) Sprout Capital VIL, L.P. (1998) (Healthcare Technology) Sprout Capital VII, L.P. (1995) (Healthcare Technology) Sprout Growth II, L-P. (1995) (Healthcare Technology) Paid-In Distributed Equity In Total Distributed / Total Value/ Total Value Capital Value Fund Value Paid In Paid In IRR Fund Size New Leaf Ventures II, L.P. (2008) $450.0 $407.3 204.2 $386.9 591.1 0.50x 1.45x 16.7% New Leaf Ventures I, L.P. (2005) $310.0 $302.6 154.7 $374.8 529.5 0.51x 1.75x 12.0% Sprout Capital IX, L-P. (2000) (Healthcare Technology) 1,071.5 $71.1 Sprout Capital VIIL, L-P. (1998) (Healthcare Technology) $147.1 $147.1 218.7 $0.0 218.7 1.49x 1.49x 6.0% Sprout Capital VII, L.P. (1995) (Healthcare Technology) 207.0 $56.3 Sprout Growth IL, L.P. (1995) (Healthcare Technology) 94 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024105

Have a question about what this document contains?

Ask the documents